Cargando…
Bridging the gap between efficacy trials and model-based impact evaluation for new tuberculosis vaccines
In Tuberculosis (TB), given the complexity of its transmission dynamics, observations of reduced epidemiological risk associated with preventive interventions can be difficult to translate into mechanistic interpretations. Specifically, in clinical trials of vaccine efficacy, a readout of protection...
Autores principales: | Tovar, Mario, Arregui, Sergio, Marinova, Dessislava, Martín, Carlos, Sanz, Joaquín, Moreno, Yamir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884451/ https://www.ncbi.nlm.nih.gov/pubmed/31784512 http://dx.doi.org/10.1038/s41467-019-13387-9 |
Ejemplares similares
-
On the impact of masking and blocking hypotheses for measuring the efficacy of new tuberculosis vaccines
por: Arregui, Sergio, et al.
Publicado: (2016) -
Data-driven model for the assessment of Mycobacterium tuberculosis transmission in evolving demographic structures
por: Arregui, Sergio, et al.
Publicado: (2018) -
Modeling the impact of COVID-19 on future tuberculosis burden
por: Tovar, Mario, et al.
Publicado: (2022) -
Projecting social contact matrices to different demographic structures
por: Arregui, Sergio, et al.
Publicado: (2018) -
MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice
por: Aguilo, Nacho, et al.
Publicado: (2016)